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Argentina, Belgium (French and Flemish), France, Romania, Czech Republic, Slovakia, 
Poland and Russia. METHODS: The adaptation in each country required 3 stages: 
Translation, cognitive debrieﬁng and a validation survey. The translation process 
adopted the dual panel (bilingual followed by lay panel) methodology to ensure the 
‘naturalness’ of language. Cognitive-debrieﬁng interviews assessed face and content 
validity with local RA patients. The validation survey tested the psychometric proper-
ties of the new scales and included the Nottingham Health Proﬁle (NHP) as a com-
parator. RESULTS: The sample size for France was inadequate to test its psychometric 
properties. Mean scores on the new versions of the RAQoL ranged from 10.7 to 15.7 
(maximum possible  30). Internal consistency ranged from 0.90–0.97 and test-retest 
reliability from 0.85–0.99 with 7 countries above 0.90. Scores were related to self-
perceived severity in all countries, reaching signiﬁcance in 7 out of 10 countries and 
were signiﬁcantly related to self-perceived general health in all countries. Mean cor-
relations with NHP sections were highest (as expected) with energy level, pain and 
physical mobility (average correlations 0.71–0.74) and lowest with emotional reac-
tions, sleep disturbance and social isolation (average correlations 0.50–0.67). CON-
CLUSIONS: The present study indicates that (with the exception of France which 
requires additional validation data) the new language versions of the RAQoL meet 
the standards of the original UK version and the other 8 existing versions. The new 
instruments represent valid and reliable tools for measuring QoL in international 
clinical trials in RA.
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OBJECTIVES: To assess the impact of psoriatic arthritis on the quality of life of 
patients due to the illness. METHODS: An observational study was designed recruit-
ing 287 patients from 18 Spanish centers to assess psoriatic arthritis patients’ quality 
of life. Data about the demographic characteristics of the sample were collected. 
Measures of the severity of the psoriatic arthritis were: 1) Psoriasis Area and Severity 
Illness (PASI scores 0–72, from low to high severity of psoriasis); 2) Number of painful 
or inﬂamed joints; 3) Health Assessment Questionnaire (HAQ; assessment of illness 
impact in different types of activities). Assessment of health-related quality of life 
(HRQL) was performed using: 1) Quality of life questionnaire EuroQol-5D (EQ-5D 
scores 0–3; higher scores are related to worse HRQL) and its Visual Analogue Scale 
(VAS scores 0–100; higher scores represent a best HQRL); and 2) Quality of life 
questionnaire Short Form-36 (SF-36 scores 0–100; higher scores are related to best 
HRQL). Frequency distribution, means and SD of the data were shown. RESULTS: 
The majority of cases were males (55.7%) and the mean age was 52.40 o 12.53 years. 
Mean number of inﬂamed joints was 2.62 o 4.06 and mean number of painful joints 
was 4.97 o 6.85. Mean value of PASI scores was 3.73 o 5.83. Biologic drugs were 
used in 25% of the patients. Mean values in the domains of EQ-5D with a worst 
self-assessment were: pain, 1.86 o 0.56 and usual activities, 1.52 o 0.55. Mean score 
of VAS was 60.41 o 20.08. Domains in SF-36 where the patients report a worst 
functioning were: physic role, 50.76 o 43.43, body pain, 49.35 o 25.69, general health, 
43.78 o 19.75, vitality 50.01 o 22.58 and physical summary component, 37.88 o 
10.87. This tendency is related to the results shown in HAQ questionnaire where more 
than 40% of patients have some difﬁculties in daily/usual activities. CONCLUSIONS: 
Psoriatic arthritis is associated with an impairment of HRQL that is mainly character-
ized by body pain and a worst functioning in daily activities.
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OBJECTIVES: Obesity is often considered as a risk-factor for higher complication rates 
and worse clinical outcome of fusion surgery in the lumbar spine and is therefore 
sometimes not performed in obese patients despite relative indication for surgery. The 
goal of this study was to evaluate whether BMI is a predictive factor for clinical 
outcome after monosegmental fusion surgery in the lumbar spine. METHODS: The 
present study is a retrospective analysis of prospectively collected data in a consecutive 
series of patients. Between April 2002 and April 2007, a total of 467 patients under-
went monosegmental lumbar fusion in a single spine center. Preoperatively, at 6 weeks 
and at 1 year follow-up, SF36 and Oswestry-Disability-Index scores were collected. 
We excluded patients who underwent surgery due to infections, tumor and trauma, as 
well as revision surgeries, and all patients with incomplete datasets, so that 223 patients 
were included in the study. Of those patients, variables considered as risk-factors like 
age, BMI and the presence of comorbidities like diabetes mellitus were assessed from 
the medical records. A multiple regression model for those parameters and clinical 
outcome was cretated. RESULTS: In an unadjusted model, BMI did not at all predict 
clinical outcome, in a multivariate model adjusted for baseline outcome values of SF36, 
Oswestry-Disability index and age, a slight trend towards negative correlation between 
BMI and outcome could be shown (p  0.06) at one-year follow-up. CONCLUSIONS: 
This study suggests that BMI alone is not a good predictor of clinical outcome of 
monosegmental lumbar fusion one year after surgery and that therefore this kind 
of surgery should not be withheld from patients only because of obesity.
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OBJECTIVES: The aim was to study differences in baseline scores of two health 
related quality of life (HRQOL) hip/knee osteoarthritis questionnaires, between dif-
ferent anxiety levels. METHODS: We applied questionnaires in a sample before 
intervention. The questionnaires were OAKHQOL, score from 0 (the worst) to 100 
(the best); WOMAC with a range from 0 (the best) to 100 (the worst); and one item 
about anxiety which grouped patients into 5 levels. We categorized into 3 groups: 
“nothing/a little anxious”, “moderately anxious” and “very/extremely anxious”. We 
analyzed differences through analysis of variance with Scheffé’s test. RESULTS: 729 
patients were included. The anxiety groups were: 411 “noting/a little anxious”, 218 
“moderately anxious” and 100 “very/extremely anxious”. We found worse scores as 
anxiety level increase and statistically signiﬁcant differences (p  0.001) in nearly all 
OAKHQOL dimensions. In physical activity, mean (DS) of 31.44 (20.87) in the lowest 
group, 22.91(15.19) in “moderately”, and 14.56(13.34) in “very/extremely” group; 
in pain we observed 36.53(25.45) in “noting/little”, 24.96(19.61) in “moderately”, 
and 17.23(16.91) in “very/extremely” group; in mental health, 61.39(20.63) in the 
lowest group, 41.30(18.38) in moderate, and 24.75(13.05) in the highest group; and 
in social activities we observed differences (p  0.002) between the lowest (mean 59.07 
(26.84)) and the highest anxiety groups, (49.59 (26.05)). Social support didn’t show 
any relation. In WOMAC there were differences (p  0.001) amongst the three anxiety 
groups. In pain, the baseline score was 47.73 (19.24) in “nothing/little group, 55.23 
(16.77) in “moderately” and 63.99 (18.38) in “very/extremely anxious”; in stiffness, 
were 47.04 (24.29) in the lowest group, 53.88 (21.70) in moderate and 61.25 (26.32) 
in the highest anxiety group; ﬁnally, the baseline data in functionality were 52.58 
(20.36) in the lowest group, 60.29 (16.98) in moderate, and 69.44 (18.56) in the 
highest anxiety group. CONCLUSIONS: These ﬁndings show an association between 
anxiety levels and HRQOL baseline scores.
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OBJECTIVES: Decision-making in Rheumatoid arthritis (RA) is often based on non-
speciﬁc disease outcome measures as improvement in Health-Related Quality of Life 
(HRQoL). It is therefore crucial that HRQoL discriminate across RA severity. Several 
utility measures have been validated, from either direct (i.e. standard gamble) or 
indirect methods (i.e. EuroQol [EQ-5D], Brazier’s Short Form-6D [SF-6D], VAS-
QoL). These utility values are commonly mapped to the Health Assessment Question-
naire (HAQ) to discriminate HRQoL across different RA disease states. We evaluated 
whether the EQ-5D, SF-6D and the VAS would lead to similar utility values and dis-
criminate across disease severity among a cohort of RA patients in Portugal. 
METHODS: Using a biannual cohort of Portuguese RA patients since 2003 (NDB-
Portugal), a total of 713 patients were included in this study. Utility measures were 
assigned to each level of HAQ using 0.50 intervals. Mean and standard deviation 
utility measures were calculated using the last observation per patient. RESULTS: 
Utilities decreased as HAQ scores worsened. The mean utility values of patients varied 
signiﬁcantly depending on the measurement method. Mean utility measured using the 
EuroQOL-5D was 0.48 and mean HAQ was 1.4 (0–3, 3 corresponding to the worst 
disability). Utilities per HAQ intervals using SF-6D did not differentiate across levels 
of disease severity (HAQ 0–0.5  0.67 ; HAQ 2.5–3  0.55). The EQ-5D differentiated 
more across the severity groups (HAQ 0–0.5  0.83 ; HAQ 2.5–3  0.08). VAS-Qol 
only discriminated marginally (HAQ 0–0.5  0.74 ; HAQ 2.5–3  0.45). CONCLU-
SIONS: In a cohort of Portuguese RA patients, different utility measurement in- 
struments resulted in different utility scores. Furthermore, not all utility measures 
discriminated across disease severity. Decision-making relying on these measures, the 
results of this analysis show that different utility measurement instruments may lead 
to signiﬁcantly different results. This may lead to potentially different resource alloca-
tion decisions.
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OBJECTIVES: The aim of this study was to determine the reliability and validity of 
the Social Functioning Scale (SFS) for the Turkish MSDs (Musculoskeletal disorders) 
